Boehringer terminates insulin deal with Lilly

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jan, 2013

Singapore: Eli Lilly and Boehringer Ingelheim are making a slight adjustment to their diabetes alliance with respect to LY2605541, Lilly's novel basal insulin analog. Lilly is re-assuming ...Read more

Cellmid gets positive sign with Midkine antibody for kidney disease

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

Singapore: Australia's Cellmid has completed its first in-life diabetic nephropathy study with anti-midkine antibodies (MK-Ab) in a mouse model of the disease. Two of Cellmid's proprietary ...Read more

Takeda Gemini II trial shows positive results

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 14 May, 2012

Singapore: Positive results were reported from Takeda Pharmaceutical's international, randomized, placebo-controlled, double-blind GEMINI II pivotal phase III trial. The trial evaluated v...Read more

IOF, Fonterra grants $43K to Indonesian for bone R&D

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jul, 2013

Singapore: Global organization, International Osteoporosis Foundation (IOF), and New Zealand dairy firm, Fonterra have come together to fund and support research on female bone health in In...Read more

Vanda Pharma withdraws application for Fanaptum

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2013

Singapore: Vanda Pharmaceuticals has withdrawn its application from European Medicines Agency for a centralized marketing authorization for the medicine Fanaptum (iloperidone) intended to b...Read more

AbbVie invests $320 mn in bilogics manufacturing in Singapore

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

Singapore: Research based pharmaceutical company, AbbVie, has made investment of around USD320 million in Singapore to set up small molecule and biologics active drug substance manufacturin...Read more

Prana Alzheimer's trial shows +ve results

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 Apr, 2013

Singapore: Prana Biotechnology reported on the progress of its lead development asset PBT2, which is in phase II trials for Huntington disease and Alzheimer's disease. Across the two trials...Read more

Astellas to do interim analysis of cancer trial

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Apr, 2013

Singapore: Medivation and Astellas Pharma have established an updated interim analysis plan for the Prevail trial, a global phase III clinical trial evaluating Xtandi (enzalutamide) capsule...Read more

Novartis acquires cancer firm CoStim

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 18 Feb, 2014

Singapore: Global pharmaceutical firm, Novartis, has acquired CoStim Pharmaceuticals, a privately held biotechnology company, broadening its cancer immunotherapy research program. Increasi...Read more

Cytos reveals trial data allergic asthma immune modulator

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 09 Sep, 2013

Singapore: Cytos Biotechnology revealed additional results of the phase IIa clinical trial with CYT003, a first-in-class immune modulator in clinical development as a potential new treatmen...Read more

Prism to start PRI-724 trials to treat fibrosis

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 14 Jun, 2013

Singapore: Prism Pharma, a drug discovery company focused on developing small molecule technologies that modulate protein-protein interactions, announced the close of an approximately $15 m...Read more

Boehringer, Eli Lilly reveal post-hoc results for linagliptin

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

Singapore: Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Company revealed results from a post-hoc analysis, which explored the clinical effect of linagliptin on albuminuria in pati...Read more

Bayer recognizes innovation by Korean start-up

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 30 Aug, 2016

Singapore: Vital Smith, a Korean startup which focuses on developing innovative technology for diagnostics devices is recognized and acknowledged by Bayer as the final winners of its Grant...Read more

Aquavit, Green Cross sign MoU

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 09 Aug, 2012

Singapore: Green Cross, a leading biotechnology company in South Korea, has signed a memorandum of understanding (MOU) with US-based Aquavit Pharmaceuticals for strategic collaboration sur...Read more

Chugai gets Japanese nod cancer drug Kadcyla

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 23 Sep, 2013

Singapore: The Japanese Ministry of Health, Labour and Welfare has approved Oncology specializing pharmaceutical firm Chugai Pharmaceutical's anti-cancer agent Kadcyla, for HER2-positive in...Read more

Nexavar seeks marketing authorization in Japan

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 01 Oct, 2013

Singapore: Bayer HealthCare has submitted an additional application for marketing authorization to the Ministry of Health, Labour and Welfare (MHLW) in Japan for Nexavar (Sorafenib) tablets...Read more

Starpharma to receive $6 mn for overseas R&D

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 23 Nov, 2012

Singapore: Australia-based Starpharma is eligible to receive approximately $6 million cash in R&D tax incentives for overseas research activities related to VivaGel. Starpharma has made...Read more

Thermo Fisher Scientific celebrates 20th year in Singapore

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 30 Aug, 2016

Singapore: Thermo Fisher Scientific has completed 20th year of its operation in Singapore. The company celebrated the milestone on August 30, 2016 at Block 33, Marsiling Industrial Estate ...Read more